TY  - JOUR 
AU  - Díaz Rodríguez, María Elena
AU  - Gandullo-Sánchez, Lucía
AU  - Ocaña, Alberto
AU  - Pandiella Alonso, Atanasio
PY  - 2021
SN  - 2072-6694
UR  - http://hdl.handle.net/10366/171426
AB  - [EN]During recent years, a number of new compounds against HER2 have reached clinics, improving the prognosis and quality of life of HER2-positive breast cancer patients. Nonetheless, resistance to standard-of-care drugs has motivated the development...
LA  - eng
PB  - MDPI
KW  - ADC
KW  - HER2
KW  - drug resistance
TI  - Novel ADCs and strategies to overcome resistance to Anti-HER2 ADCs
DO  - 10.3390/cancers14010154
T2  - Cancers
VL  - 14
M2  - 154
ER  -